Paper7828281
Hypersensitivity and cross-reactivity to cisplatin and analogues.
Shlebak AA and 2 others. Cancer Chemother Pharmacol, 1995. Cited by 48 papers, by iCite.
Cite this record
ConductScience Library. Hypersensitivity and cross-reactivity to cisplatin and analogues. Papers, record 7828281. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7828281
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carboplatin | Major topic |
| Cisplatin | Major topic |
| Drug Hypersensitivity | Major topic |
| Cross Reactions | |
| Female | |
| Humans | |
| Middle Aged | |
| Ovarian Neoplasms |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3342471 | Positive direct antiglobulin test in a pediatric patient following high-dose cisplatin. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3342471 | PubMed |
| 2 | 3521846 | Phase I study of carboplatin (CBDCA) in children with cancer. | Cancer Treat Rep | 1986 | https://conductscience.org/library/papers/3521846 | PubMed |
| 3 | 6150229 | No increase in allergic reactions with intracavitary administration of cisplatin. | Lancet | 1984 | https://conductscience.org/library/papers/6150229 | PubMed |
| 4 | 3420679 | Cisplatin-induced nonimmunologic adsorption of immunoglobulin by red cells. | Transfusion | 1988 | https://conductscience.org/library/papers/3420679 | PubMed |
| 5 | 387223 | Toxic effects of cis-dichlorodiammineplatinum(II) in man. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/387223 | PubMed |
| 6 | 6134149 | Anaphylactic reactions to repeated intravesical instillation with cisplatin. | Lancet | 1983 | https://conductscience.org/library/papers/6134149 | PubMed |
| 7 | 487238 | Anaphylactoid reaction to mannitol. | Can Anaesth Soc J | 1979 | https://conductscience.org/library/papers/487238 | PubMed |
| 8 | 91439 | Chemotherapy for testicular cancer: current status of the National Cancer Institute Combined Modality Trial. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/91439 | PubMed |
| 9 | 6883356 | Phase I clinical trial of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) (CHIP). | Cancer Treat Rep | 1983 | https://conductscience.org/library/papers/6883356 | PubMed |
| 10 | 7201343 | Intravesical cisplatin for superficial bladder tumors. | Cancer | 1982 | https://conductscience.org/library/papers/7201343 | PubMed |
| 11 | 6761010 | Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6761010 | PubMed |
| 12 | 50881 | Atopic hypersensitivity to cis-dichlorodiammineplatinum(II) and other platinum complexes. | Cancer Res | 1975 | https://conductscience.org/library/papers/50881 | PubMed |
| 13 | 7127319 | Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II). | Cancer Res | 1982 | https://conductscience.org/library/papers/7127319 | PubMed |
| 14 | 6788166 | Haemolytic anaemia after cisplatin treatment. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6788166 | PubMed |
| 15 | 6204520 | [Allergic reaction to CDDP: report of 4 cases]. | Hinyokika Kiyo | 1984 | https://conductscience.org/library/papers/6204520 | PubMed |
| 16 | 3546620 | Carboplatin and recurrent childhood brain tumors. | J Clin Oncol | 1987 | https://conductscience.org/library/papers/3546620 | PubMed |
| 17 | 7188625 | Cisplatin-induced hemolysis. | N Engl J Med | 1980 | https://conductscience.org/library/papers/7188625 | PubMed |
| 18 | 6697424 | Phase-II trial of 1,2-diaminocyclohexane (4-carboxyphthalato) platinum (II) (DACCP) in non-small cell lung cancer. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6697424 | PubMed |
| 19 | 3924402 | Immediate hypersensitivity to mannitol: a potential cause of apparent hypersensitivity to cisplatin. | Cancer Treat Rep | 1985 | https://conductscience.org/library/papers/3924402 | PubMed |
| 20 | 87272 | Successful re-treatment with cis-dichlorodiammineplatinum(II) after apparent allergic reactions. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/87272 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42201461 | High-dose dexamethasone and prolonged infusion time prevent oxaliplatin-related hypersensitivity reactions in patients with metastatic colorectal cancer. | Int J Clin Oncol | 2026 | https://conductscience.org/library/papers/42201461 | PubMed |
| 35869676 | Phase II study of S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART-1501 study. | Thorac Cancer | 2022 | https://conductscience.org/library/papers/35869676 | PubMed |
| 31950013 | A case of severe hepatotoxicity induced by cisplatin and 5-fluorouracil. | Int Cancer Conf J | 2020 | https://conductscience.org/library/papers/31950013 | PubMed |
| 31819881 | Protective effect of avenanthramides against cisplatin induced nephrotoxicity in rats. | J Adv Vet Anim Res | 2019 | https://conductscience.org/library/papers/31819881 | PubMed |
| 27687047 | Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experience. | Invest New Drugs | 2017 | https://conductscience.org/library/papers/27687047 | PubMed |
| 24113520 | Nanocarriers for delivery of platinum anticancer drugs. | Adv Drug Deliv Rev | 2013 | https://conductscience.org/library/papers/24113520 | PubMed |
| 21475720 | A retrospective review of the frequency and nature of acute hypersensitivity reactions at a medium-sized infusion center: comparison to reported values and inconsistencies found in literature. | J Cancer | 2011 | https://conductscience.org/library/papers/21475720 | PubMed |
| 21355578 | Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA. | Biochemistry | 2011 | https://conductscience.org/library/papers/21355578 | PubMed |
| 20886011 | Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review. | Met Based Drugs | 2010 | https://conductscience.org/library/papers/20886011 | PubMed |
| 19856046 | Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan. | Int J Clin Oncol | 2009 | https://conductscience.org/library/papers/19856046 | PubMed |
| 18931982 | [Basophil activation test as in vitro assay for cisplatin allergy]. | Hautarzt | 2008 | https://conductscience.org/library/papers/18931982 | PubMed |
| 12888815 | Hypersensitivity reactions related to oxaliplatin (OHP). | Br J Cancer | 2003 | https://conductscience.org/library/papers/12888815 | PubMed |
| 12160138 | Hypersensitivity reactions to carboplatin in children. | J Neurooncol | 2002 | https://conductscience.org/library/papers/12160138 | PubMed |
| 11676304 | Prevention and management of antineoplastic-induced hypersensitivity reactions. | Drug Saf | 2001 | https://conductscience.org/library/papers/11676304 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7828281
GET https://conductscience.org/api/papers/v1/7828281/references?page=2